A patent review of transient receptor potential vanilloid type 1 modulators (2014–present)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A patent review of transient receptor potential vanilloid type 1 modulators (2014–present)

Published:2020-12-30 Issue:2 Volume:31 Page:169-187
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Gao Mengkang¹,Wang Yusui¹,Liu Lanqi¹,Qiao Zhenrui¹,Yan Lin¹

Affiliation:

1. School of Pharmacy, Henan University, Kaifeng, Henan, China

Funder

National Natural Science Foundation of China

Key Scientific and Technological Project of Henan Province

the Key Laboratory of Advanced Drug Preparation Technologies of Ministry of Education

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1854225

Reference50 articles.

1. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists

2. TRP Channels and Pain

3. Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field

4. Transient receptor potential vanilloid 1 antagonism in neuroinflammation, neuroprotection and epigenetic regulation: potential therapeutic implications for severe psychiatric disorders treatment

5. The capsaicin receptor: a heat-activated ion channel in the pain pathway

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, pungency and bioactivity transduction of piperine from black pepper (Piper nigrum L.): A comprehensive review;Food Chemistry;2024-10

2. Bleomycin triggers chronic mechanical nociception by activating TRPV1 and glial reaction-mediated neuroinflammation via TSLP/TSLPR/pSTAT5 signals;Brain Research Bulletin;2024-09

3. TRPV1 Channels in the Central Nervous System as Drug Targets;Pharmaceuticals;2024-06-07

4. Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects;Bioorganic & Medicinal Chemistry;2024-06

5. Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management;European Journal of Medicinal Chemistry;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3